Durham, NC -- (ReleaseWire) -- 02/13/2008 -- Heart disease is the leading cause of death in the United States, but now a powerful one-page report developed by BioSignia can help monitor your risks of developing specific chronic preventable cardiovascular diseases, such as heart disease and stroke.

Developed by a leading biotechnology company, Know Your Number® is a breakthrough disease-specific risk assessment (DRA) tool that is different from standard health risk assessment (HRA) tools. Know Your Number takes a multi-dimensional approach to determining your risk of specific diseases rather than calculating your overall health quotation, resulting in more actionable knowledge for individuals and their doctors.

"Just like a credit report helps you make more informed financial decisions, Know Your Number helps you make better decisions about your health," says Dr. Tim Smith, president and COO of BioSignia, a predictive modeling company which received the Disease Management Association of America's prestigious award for Best Enabling Tool for Disease Management in 2004. "Americans aren't following the time-tested saying that prevention is the best medicine and more individualized, risk factor-specific information is needed to spur them to action."

In 30 minutes or less, the Know Your Number assessment takes information about you, such as your weight, blood pressure, family history, lifestyle habits and key blood values. Then, it uses a proprietary technology called Synthesis Analysis™ to produce a detailed report on your risks of developing specific diseases. It's unlike any other HRA tool because it uses a multi-dimensional approach by isolating individual and aggregate data on absolute risk: what your specific risk is of developing a particular chronic disease; relative risk: how you compare to your peers; and modifiable risk: where your risk is coming from and the things relating to your lifestyle and habits that you can modify.

Know Your Number is 35% more accurate for chronic disease risk prediction than conventional HRA tools and represents a 20% greater accuracy in diabetes sensitivity than the Rotterdam Prediction Model.

Its approach is different from other HRA tools in three main ways:

1. It focuses on the main disease killers.
While other assessment tools just look at overall health, Know Your Number predicts an individual's actual risk of developing the main chronic preventable disease killers in the U.S.: heart disease, diabetes, and stroke. Traditional HRA tools are mortality-based and non-disease specific, which makes them less useful in identifying disease risk and predicting overall medical costs.

2. It shows what your specific risks are and how to reduce those risks.
This tool reveals the likelihood of developing a certain disease within the next five years, what fraction of that disease risk is modifiable, and lets you know what factors (e.g. lack of exercise, smoking) are contributing to the risks of developing specific chronic conditions. Know Your Number used a proprietary technology, Synthesis Analysis™, to deliver a multi-dimensional health risk assessment calculation that looks at all the risk, not just the overall risk. By singling out avoidable, modifiable, and non-avoidable risk, Know Your Number provides the steps individuals can take to significantly reduce their risks.

3. It provides you and your doctor an easy to understand road map to better health.
Know Your Number is a clinically-based tool that patients and physicians can use to communicate with each other. Many patients leave their doctor's office with a bill and a prescription, but without a true understanding of their health situation. Know Your Number is used by patients and physicians to get on the same page as well as track a patient's progress.

Everybody wants to reduce their risk--we wear our seatbelt to make sure we're protected in a car accident and install smoke alarms to keep our family safe. Though, individuals cannot take the necessary health preventive measures without knowing their specific risks.

"The disease risk profile itself was the most comprehensive and visible tool that our physicians have ever seen," says Tina Wise, RN, Vice President of Medical Management for Doctor's Direct, which uses Know Your Number exclusively for their wellness program. "It provided the greatest amount of information that was valuable to the patient and the physician."

Do you know your number? To learn more, visit: http://www.knowyournumber.com

About BioSignia
Headquartered in Research Triangle Park, N.C., BioSignia is a leading technology company focused on bringing innovative predictive modeling solutions to the preventive health and life insurance markets. At the core of BioSignia's flagship solution, Know Your Number is the company's proprietary synthesis modeling approach to chronic disease risk prediction. In 2004, BioSignia received the Disease Management Association of America's prestigious award for Best Enabling Tool for Disease Management. Since then, the company's talented R&D team has continued to advance synthesis modeling, continuously updating it to reflect the ever expanding need for effective chronic disease prevention, management and treatment. For more information, visit http://www.knowyournumber.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

North Carolina based pharmacy chain first in the nation to offer consumers a personalized health report that predicts the likelihood of developing diabetes and other preventable diseases

Durham, NC -- (ReleaseWire) -- 05/10/2007 -- BioSignia, a leading preventative healthcare technology company, today announced the signing of a licensing agreement with regional pharmacy chain Kerr Drug. BioSignia's health risk assessment (HRA) engine significantly improves prevention and management of chronic diseases by focusing on individualized disease risk assessment (DRA).

Under terms of the agreement, BioSignia's revolutionary Know Your Number® testing tool will be available to customers at participating Kerr Health Care Centers in North Carolina. Know Your Number is currently not available through any other pharmacy chain nationwide.

Know Your Number predicts the onset of preventable diseases, compares your current health status against your peers, reveals what chronic disease risks are modifiable and lets you know what factors (e.g. lack of exercise, smoking) are contributing to the risks of developing specific chronic conditions. Findings are communicated in easy-to-interpret, visually compelling reports that also help individuals track their progress.

Kerr Drug is deeply committed to providing the highest quality health and wellness services to patients, the medical community and healthcare sponsors. Adding Know Your Number to the roster of solutions already offered at its health care centers serves to further the company's mission of being the premier community pharmacy in North Carolina.
"Know Your Number is, by no means, a standard health risk assessment tool," commented Joe Heidrick, R.Ph., PharmD and program coordinator at Kerr Drug. "It evaluates and reports a person's chances of developing a chronic disease in a much more accurate, actionable manner."

Driven by a powerful, patented predictive technology, Know Your Number is the first and only clinically based multi-dimensional tool to predict an individual's risk of onset, progression, or life expectancy related to multiple chronic diseases.
"We are extremely excited at the opportunity to work with one of the most recognized and respected retail organizations in the nation," commented Tim Smith, CEO of BioSignia. "We firmly believe in the power of the Know Your Number solution and the benefits it will deliver to Kerr Drugs' customers."

About BioSignia
Headquartered in Research Triangle Park, NC, BioSignia is a leading technology company focused on bringing innovative predictive modeling solutions to the preventive health and life insurance markets. At the core of BioSignia's flagship solution, Know Your Number, is the company's proprietary synthesis modeling approach to chronic disease risk prediction. In 2004, BioSignia received the Disease Management Association of America's prestigious award for Best Enabling Tool for Disease Management. Since then, the company's talented R&D team has continued to advance synthesis modeling, continuously updating it to reflect the ever expanding need for effective chronic disease prevention, management and treatment. For more information, visit www.knowyournumber.com.

About Kerr Drug
Kerr Drug is one of the most recognized and respected names in the chain drug industry. With its roots in the Carolinas and headquarters in Raleigh, North Carolina, Kerr Drug is taking the vision of community pharmacy farther than any other drug chain. The company has placed its future on its unique ability to provide patients, the medical community, and health plan sponsors, access to the most comprehensive and convenient health and wellness offering in the industry. With a mission to be the most comprehensive provider of pharmacy and related health care services, while continuing to be the most reliable provider of health related and convenience items, Kerr is currently providing services that far exceed the traditional drug store mix. For more information, please visit www.kerrdrug.com.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Burgeoning healthcare technology company selects marketing partner to drive national marketing rollout of company’s evidence-based chronic disease prediction models.

Durham, NC -- (ReleaseWire) -- 04/30/2007 -- BioSignia, a leading technology company focused on innovative solutions for chronic disease prevention and management, today announced the signing of a marketing services agreement with 919 Marketing Company. With offices in Holly Springs N.C. and Washington D.C., 919 is a nationally recognized marketing consulting and public relations firm focused on the health and wellness market.

Accurately assessing the likelihood that individuals will develop a chronic, preventable disease resulting in poor quality of life, declining productivity and higher healthcare costs has become a major concern of healthcare providers, insurers, and employers alike. BioSignia's patented flagship Know Your Number™ preventive health and wellness engine significantly improves early detection, prevention and management of chronic diseases. In addition, the company's cutting-edge underwriting technology enables life insurance companies to attract and retain higher value customers, as well as to bring new products to market more speedily and efficiently.

Driven by a powerful, patented predictive technology, Know Your Number is the first and only multi-dimensional tool to predict the risk of onset, progression, or life expectancy related to multiple chronic diseases.

The company's decision to sign on with 919 Marketing was based on the need to accelerate market awareness and adoption of Know Your Number in the healthcare, employee wellness, insurance and consumer health sectors.

"Selecting the right marketing partner was a key component in meeting our aggressive market growth goals, so naturally we conducted a thorough evaluation process prior to engaging 919 Marketing," said BioSignia's CEO, Dr. Tim Smith. "Their successful track record in developing fresh channel marketing strategies, methodologies for developing and validating the winning Biosignia brand strategy and their roster of related "health and wellness" accounts best dovetailed our marketing needs."

The agreement with BioSignia calls for 919 Marketing to provide ongoing marketing strategy and program management, national advertising and public relations planning and implementation, sales materials, direct marketing and more.

"We are excited to have been selected to drive the marketing efforts of what promises to be the new gold standard for the early detection of chronic disease risks," said David Chapman, CEO of 919. "Our work for Know Your Number allows us to be at the forefront of shaping the personalized health and wellness categories," added Chapman.

About BioSignia
Headquartered in Research Triangle Park, NC, BioSignia is a leading technology company focused on bringing innovative predictive modeling solutions to the preventive health and life insurance markets. At the core of BioSignia's flagship solution, Know Your Number, is the company's proprietary synthesis modeling approach to chronic disease risk prediction. In 2004, BioSignia received the Disease Management of America's prestigious award for Best Enabling Tool for Disease Management. Since then, the company's talented R&D team has continued to advance synthesis modeling, continuously updating it to reflect the ever expanding need for effective chronic disease prevention, management and treatment. For more information, visit www.knowyournumber.com.

About 919 Marketing Company
919 Marketing is a nationally recognized marketing consulting and public relations firm with a proven track record of helping underdog companies of all sizes discover their competitive advantage and drive profitable business growth. Headquartered just outside of North Carolina's Research Triangle Park with a satellite office in downtown Washington D.C., 919 was founded over a decade ago by CEO David Chapman.

919 is an unconventional firm with an uncanny ability to develop winning marketing strategies for a roster of companies including Biosignia, Cornerstone Biopharma, Coalition to Salute America's Heroes, Jersey Mike's, Kerr Drug, The Rosetta Stone, Social Technologies and Unilever Brands.

919 Marketing provides strategic planning, public relations, interactive marketing and creative development services - each utilizing proven processes that have been refined and validated over hundreds of client engagements. For more information on 919 Marketing, please call 919.557.7890 or visit www.919marketing.com.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm